The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality
Recruiting
Phase 4
Interventional Study
GLP - 1
Bowel Preparation for Colonoscopy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 132 (estimated)
- Sponsor
- The Cleveland Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn how GLP-1 and GIP agonists effect bowel preparation in patients scheduled for colonoscopies. The main questions it aims to answer are:
* Does GLP-1 and GIP agonist increase the rate of inadequate bowel preparation?
* Does the quality of bowel preparation differ in patients who hold vs. those who continue a single dose of their GLP-1 or GIP agonist medic…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patient (Age 18 years or older)
* Patient scheduled for outpatient screening, surveillance, or diagnostic colonoscopy
* Using a GLP-1 or GIP agonist at a stable dose for at least one month
Exclusion Criteria:
* Unable to provide informed consent, e.g., dementia
* Patie…
Contacts
No contact information available.